CASI Pharmaceuticals, Inc., a biopharmaceutical company, develops and markets therapeutic and pharmaceutical products in China, the United States, and internationally. The company is headquartered in Rockville, Maryland. Show more

1701-1702, CHINA CENTRAL OFFICE TOWER 1, BEIJING, CHINA, 100025, Beijing, 100025, China

https://www.casipharmaceuticals.com

BIOTECHNOLOGY

HEALTHCARE

Start AI Chat

Market Cap

4.264M

52 Wk Range

$0.21 - $3.09

Previous Close

$0.21

Open

$0.21

Volume

N/A

Day Range

$0.21 - $0.21

Enterprise Value

16.88M

Cash

4.685M

Avg Qtr Burn

N/A

Insider Ownership

87.27%

Institutional Own.

32.60%

Qtr Updated

09/30/25

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
EVOMELA (melphalan) Details Multiple myeloma	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Inaticabtagene Autoleucel (CNCT-19) (Anti-CD19) Details Non-Hodgkin lymphoma	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
BI-1206 (Anti-FcyRIIB antibody) + rituximab Details Blood cancer, Non-Hodgkin lymphoma, Solid tumor/s, Cancer	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CID-103 Details Renal Allograft Antibody-Mediated Rejection (AMR)	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CID-103 Details Immune Thrombocytopenia (ITP)	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
CB-5339 Details Multiple myeloma	Phase 1 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.